Nicorandil-induced painful aphthae or ulcerations

被引:0
|
作者
Boulinguez, S [1 ]
Bonnetblanc, JM [1 ]
机构
[1] CHU Dupuytren, Serv Dermatol, F-87042 Limoges, France
来源
PRESSE MEDICALE | 2000年 / 29卷 / 33期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A recognized cause of buccal aphthosis: Nicorandil is the leading drug in a new pharmacology class of well tolerated anti-angina products with vasodilating action. The first cases of buccal aphthosis or ulcerations induced by nicorandil were reported in 1996, Among drugs inducing buccal aphthosis or ulcerations, the largest body of information available on reported cases concern nicorandil. Characteristic lesions: Forty cases of painful buccal lesions induced by nicorandil have been recorded. Among the 8 publications in the literature, 7 were reported by French groups. The prevalence of this adverse effect is an estimated 5%. Patient age varies from 60 to 90 years with an even gender distribution. A history of aphthosis is noted in 23% of the cases. The lesions vary in size from 0.5 cm to 3 cm and in number from 1 to 10, generally localized on the inner aspect of the cheeks or on the tongue. The lesions develop for about 3 to 36 before diagnosis and the delay to onset of signs after initiating nicorandil treatment is 15 days to 24 months (generally 2 months). Lesions basically develop after high-dose treatments and, for a few cases, after increasing the dosage, Cure is obtained in ail cases after 1 to 12 weeks. Open questions: The probability that nicorandil is the cause of these ulcerations or aphthae is very high. Certain terms do however need to be defined with precision. Are we talking about aphthae or ulcerations ? The term painful ulceration would appear to be preferable because it includes both ulcerations and aphthae in cases lacking further information. The wide variability in the geographical distribution could likely be linked to underreporting, The notion of a dose effect suggests a toxic mechanism that could develop in predisposed populations (ethnic origin...) and would be directed against buccal targets (salivary glands...) via the active drug or its metabolites or via drug interactions. This new adverse effect of nicorandil is quite spectacular and very painful. However, no life-threatening event has been observed.
引用
收藏
页码:1828 / 1832
页数:5
相关论文
共 50 条
  • [31] CYCLIC-GMP IN NICORANDIL-INDUCED VASODILATATION AND TOLERANCE DEVELOPMENT
    KUKOVETZ, WR
    HOLZMANN, S
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 : S25 - S30
  • [32] Dual pathology: cervicofacial actinomycosis and nicorandil-induced oral ulceration
    Cupples, H. E. V.
    McGahey, D. T.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2008, 122 (04): : 422 - 424
  • [33] RECURRENT PAINFUL APHTHAE
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1957, 163 (05): : 409 - 409
  • [34] Two cases of nicorandil-induced ulceration mimicking skin malignancy
    Sharma, A.
    Orpin, S.
    Goulding, J.
    Kaur, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (03) : 662 - 663
  • [35] Nicorandil-induced Isolated Abducens Nerve Palsy: A Case Report
    Kutsuna, Fumiya
    Setsu, Katsuyoshi
    Hattori, Fumitada
    INTERNAL MEDICINE, 2025,
  • [36] Nicorandil-induced relaxation in the human internal mammary and radial arteries
    Chen, ZW
    Yang, Q
    He, GW
    FASEB JOURNAL, 2005, 19 (04): : A107 - A107
  • [37] Nicorandil-Induced Bullous Fixed Drug Eruption on the Glans Penis
    Ghosh, Sudip
    Majumder, Biswajit
    Mondal, Satarupa
    INDIAN JOURNAL OF DERMATOLOGY, 2022, 67 (05)
  • [38] Buccal ulcerations induced by nicorandil: prevalence and clinicopathologic study
    Marquart-Elbaz, C
    Lipsker, D
    Grosshans, E
    Cribier, B
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1999, 126 (8-9): : 587 - 590
  • [39] Nicorandil-induced ulceration of the penis (vol 33, pg 215, 2008)
    Dearing, N.
    Carlin, E.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2008, 33 (03) : 380 - 380
  • [40] Nicorandil-induced severe oral ulceration - A newly recognized drug reaction
    Shotts, RH
    Scully, C
    Avery, CM
    Porter, SR
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1999, 87 (06): : 706 - 707